Trials / Unknown
UnknownNCT01992731
IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.
IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 138 (estimated)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- Female
- Age
- 38 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
Prospective randomised controlled trial: 3 IUI cycles versus 1 IVF/ICSI cycle in women aged 38-42 years.
Detailed description
Study design: Prospective randomised controlled trial: 3 IUI cycles versus 1 IVF/ICSI cycle in women aged 38-42 years. . Group 1: 3 consecutive gonadotrophin stimulated IUI cycles (Follitropine Bèta, Puregon, MSD). vs. Group 2: 1 IVF/ ICSI cycle - Recombinant FSH (Follitropine Bèta, Puregon, MSD) - Antagonist protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Drug: Follitropine Bèta |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-12-01
- Completion
- 2017-03-01
- First posted
- 2013-11-25
- Last updated
- 2015-03-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01992731. Inclusion in this directory is not an endorsement.